Mega Lifesciences Public Company Limited (MEGA.BK)
- Previous Close
41.25 - Open
41.00 - Bid 40.50 x --
- Ask 40.75 x --
- Day's Range
40.25 - 41.25 - 52 Week Range
34.75 - 46.75 - Volume
617,594 - Avg. Volume
893,060 - Market Cap (intraday)
35.311B - Beta (5Y Monthly) 0.40
- PE Ratio (TTM)
17.69 - EPS (TTM)
2.29 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield 1.60 (3.95%)
- Ex-Dividend Date Mar 6, 2024
- 1y Target Est
48.94
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids', men's, and women's care products. The company also offers prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardiovascular system, dermatology, diabetes, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology. In addition, it provides logistical and marketing services for the sale of goods manufactured by third parties, as well as involved in the software design, development, and other services business. The company was founded in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited operates as a subsidiary of Unistretch Limited.
www.megawecare.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: MEGA.BK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEGA.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEGA.BK
Valuation Measures
Market Cap
35.31B
Enterprise Value
32.85B
Trailing P/E
17.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.25
Price/Book (mrq)
3.80
Enterprise Value/Revenue
2.09
Enterprise Value/EBITDA
12.74
Financial Highlights
Profitability and Income Statement
Profit Margin
12.68%
Return on Assets (ttm)
12.77%
Return on Equity (ttm)
22.04%
Revenue (ttm)
15.72B
Net Income Avi to Common (ttm)
1.99B
Diluted EPS (ttm)
2.29
Balance Sheet and Cash Flow
Total Cash (mrq)
2.72B
Total Debt/Equity (mrq)
2.71%
Levered Free Cash Flow (ttm)
1.42B
Research Analysis: MEGA.BK
Company Insights: MEGA.BK
MEGA.BK does not have Company Insights